This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: ACE inhibitors

Underuse of beta blockers in patients with heart failure

March 2013 Br J Cardiol 2013;20:11–13 doi:10.5837/bjc.2013.005

Underuse of beta blockers in patients with heart failure

Laxman Dubey, Paul Kalra, Henry Purcell

Abstract

Our letter from Nepal below shows underuse of beta blockers is a widespread problem As outlined in the recent European Society of Cardiology (ESC) guidelines for the treatment of heart failure,1 the pivotal trials with beta blockers were conducted in patients with continuing symptoms and a persistently low ejection fraction (EF), despite treatment with an ACE inhibitor and, in most cases, a diuretic. Despite this, “there is consensus that these treatments are complementary and that a beta blocker and an ACE inhibitor should both be started as soon as possible after diagnosis of heart failure with reduced ejection fraction (HF-REF)”.1

| Full text
Optimising hypertension treatment: NICE/BHS guideline implementation and audit for best practice

March 2013 Br J Cardiol 2013;20(suppl 1): S1–S16 doi:10.5837/bjc.2013.s01

Optimising hypertension treatment: NICE/BHS guideline implementation and audit for best practice

Dr Terry McCormack, Dr Chris Arden, Dr Alan Begg, Professor Mark Caulfield, Dr Kathryn Griffith, Ms Helen Williams

Abstract

(more…)

| Full text
News from the 2010 Congress of the European Society of Cardiology

September 2010 Br J Cardiol 2010;17:211-14

News from the 2010 Congress of the European Society of Cardiology

Abstract

Highlights of this year’s European Society of Cardiology Congress, held in Stockholm, Sweden, from August 28th to September 1st included a new drug which benefits heart failure by slowing heart rate, and more exciting results from oral compounds that could replace warfarin in various indications. Highlights of this year’s European Society of Cardiology Congress, held in Stockholm, Sweden, from August 28th to September 1st included a new drug which benefits heart failure by slowing heart rate, and more exciting results from oral compounds that could replace warfarin in various indications. SHIFT: ivabradine shows benefit in heart failure

| Full text

January 2005 Br J Cardiol 2005;12:65-70

Evidence-based treatment of hypertension: what’s the role of angiotensin II receptor blockers?

FD Richard Hobbs, Peter Irwin, Janet Rubner

Abstract

No content available

| Full text

January 2003 Br J Cardiol 2003;10:36-43

Prescribing of ACE inhibitors and statins after bypass surgery: a missed opportunity for secondary prevention?

R Andrew Archbold, Azfar G Zaman, Nicholas P Curzen, Peter G Mills

Abstract

No content available

| Full text

March 2002 Br J Cardiol 2002;9:158-62

The clinical application of ACE inhibitors in coronary artery disease

Abba Gomma, John Henderson, Henry Purcell, Kim Fox

Abstract

No content available

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now